Optimum doses of irinotecan

Lancet. 1999 Apr 10;353(9160):1275-6. doi: 10.1016/s0140-6736(05)75197-7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aged
  • Antineoplastic Agents, Phytogenic / administration & dosage*
  • Camptothecin / administration & dosage
  • Camptothecin / analogs & derivatives*
  • Colorectal Neoplasms / drug therapy*
  • Drug Administration Schedule
  • Humans
  • Irinotecan
  • Topoisomerase I Inhibitors

Substances

  • Antineoplastic Agents, Phytogenic
  • Topoisomerase I Inhibitors
  • Irinotecan
  • Camptothecin